The therapeutic effect of vascular endothelial growth factor gene- or heme oxygenase-1 gene-modified endothelial progenitor cells on neovascularization of rat hindlimb ischemia model
- 1 September 2013
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 58 (3) , 756-765.e2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cellular Therapy With Ixmyelocel-T to Treat Critical Limb Ischemia: The Randomized, Double-blind, Placebo-controlled RESTORE-CLI TrialMolecular Therapy, 2012
- Decreased Circulating Endothelial Progenitor Cell Levels and Function in Patients with Nonalcoholic Fatty Liver DiseasePLOS ONE, 2012
- Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemiaJournal of Vascular Surgery, 2011
- Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemiaJournal of Vascular Surgery, 2011
- Impaired Endothelial Repair Capacity of Early Endothelial Progenitor Cells in PrehypertensionHypertension, 2010
- Endothelial Progenitor Cells as a Therapeutic Option in Peripheral Arterial DiseaseEuropean Journal of Vascular and Endovascular Surgery, 2009
- Endothelial progenitor cells: identity defined?Journal of Cellular and Molecular Medicine, 2009
- ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)Circulation, 2006
- Endothelial Progenitor CellsCirculation Research, 2004
- Therapeutic Angiogenesis in Peripheral Arterial Disease: Can Biotechnology Produce an Effective Collateral Circulation?European Journal of Vascular and Endovascular Surgery, 2004